{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:15:31Z","timestamp":1726845331099},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12032-016-0844-7","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T10:56:56Z","timestamp":1476874616000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A\/p16 mRNA: a combined strategy to cervical cancer diagnosis"],"prefix":"10.1007","volume":"33","author":[{"given":"Mario Cezar","family":"Saffi Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivone da Silva","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Barbosa de Oliveira","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana Garcia","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Makabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Dell\u00ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleber P.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"issue":"3","key":"844_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0034-8910.2014048005214","volume":"48","author":"VR Girianelli","year":"2014","unstructured":"Girianelli VR, Gamarra CJ, Azevedo e Silva G. Disparities in cervical and breast cancer mortality in Brazil. Rev Saude Publ. 2014;48(3):459\u201367.","journal-title":"Rev Saude Publ"},{"issue":"4","key":"844_CR2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1991.03460040048027","volume":"265","author":"HM Bauer","year":"1991","unstructured":"Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265(4):472\u20137.","journal-title":"JAMA"},{"issue":"18","key":"844_CR3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","volume":"327","author":"LA Koutsky","year":"1992","unstructured":"Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327(18):1272\u20138. doi: 10.1056\/NEJM199210293271804 .","journal-title":"N Engl J Med"},{"issue":"1","key":"844_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0984","volume":"5","author":"A Psyrri","year":"2008","unstructured":"Psyrri A, DiMaio D. Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol. 2008;5(1):24\u201331. doi: 10.1038\/ncponc0984 .","journal-title":"Nat Clin Pract Oncol"},{"issue":"5","key":"844_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H Zur Hausen","year":"2002","unstructured":"Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350. doi: 10.1038\/nrc798 .","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"844_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1525-1381.1999.99723.x","volume":"111","author":"H Zur Hausen","year":"1999","unstructured":"Zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Phys. 1999;111(6):581\u20137.","journal-title":"Proc Assoc Am Phys"},{"issue":"3","key":"844_CR7","first-page":"286","volume":"130","author":"RS Jayshree","year":"2009","unstructured":"Jayshree RS, Sreenivas A, Tessy M, Krishna S. Cell intrinsic and extrinsic factors in cervical carcinogenesis. Indian J Med Res. 2009;130(3):286\u201395.","journal-title":"Indian J Med Res"},{"issue":"7","key":"844_CR8","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1073\/pnas.0409883102","volume":"102","author":"T Brake","year":"2005","unstructured":"Brake T, Lambert PF. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA. 2005;102(7):2490\u20135. doi: 10.1073\/pnas.0409883102 .","journal-title":"Proc Natl Acad Sci USA"},{"key":"844_CR9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oxfordjournals.jncimonographs.a003473","volume":"31","author":"M Stanley","year":"2003","unstructured":"Stanley M. Chapter 17: genital human papillomavirus infections\u2013current and prospective therapies. J Natl Cancer Inst Monogr. 2003;31:117\u201324.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"844_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/mi.2008.33","volume":"1","author":"A Kobayashi","year":"2008","unstructured":"Kobayashi A, Weinberg V, Darragh T, Smith-McCune K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008;1(5):412\u201320. doi: 10.1038\/mi.2008.33 .","journal-title":"Mucosal Immunol"},{"issue":"3","key":"844_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","volume":"41","author":"HJ Ball","year":"2009","unstructured":"Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol. 2009;41(3):467\u201371. doi: 10.1016\/j.biocel.2008.01.005 .","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"844_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jri.2003.11.004","volume":"61","author":"Y Kudo","year":"2004","unstructured":"Kudo Y, Boyd CA, Spyropoulou I, Redman CW, Takikawa O, Katsuki T, et al. Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol. 2004;61(2):87\u201398. doi: 10.1016\/j.jri.2003.11.004 .","journal-title":"J Reprod Immunol"},{"issue":"1","key":"844_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbrc.2005.09.032","volume":"338","author":"O Takikawa","year":"2005","unstructured":"Takikawa O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism. Biochem Biophys Res Commun. 2005;338(1):12\u20139. doi: 10.1016\/j.bbrc.2005.09.032 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"844_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1349-7006.2007.00470.x","volume":"98","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, et al. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci. 2007;98(6):874\u201381. doi: 10.1111\/j.1349-7006.2007.00470.x .","journal-title":"Cancer Sci"},{"issue":"5","key":"844_CR15","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3892\/or.2012.1984","volume":"28","author":"N Sato","year":"2012","unstructured":"Sato N, Saga Y, Mizukami H, Wang D, Takahashi S, Nonaka H, et al. Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation. Oncol Rep. 2012;28(5):1574\u20138. doi: 10.3892\/or.2012.1984 .","journal-title":"Oncol Rep"},{"issue":"1","key":"844_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ajcp\/aqv019","volume":"145","author":"D Gustinucci","year":"2016","unstructured":"Gustinucci D, Giorgi Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A, et al. Use of Cytology, E6\/E7 mRNA, and p16INK4a-Ki-67 to define the management of human papillomavirus (HPV)-positive women in cervical cancer screening. Am J Clin Pathol. 2016;145(1):35\u201345. doi: 10.1093\/ajcp\/aqv019 .","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"844_CR17","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1007\/s13277-015-3480-5","volume":"36","author":"MK Sibin","year":"2015","unstructured":"Sibin MK, Bhat DI, Narasingarao KV, Lavanya C, Chetan GK. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma. Tumour Biol. 2015;36(10):7607\u201314. doi: 10.1007\/s13277-015-3480-5 .","journal-title":"Tumour Biol"},{"issue":"4","key":"844_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00003081-199012000-00017","volume":"33","author":"EJ Wilkinson","year":"1990","unstructured":"Wilkinson EJ. Pap smears and screening for cervical neoplasia. Clin Obstet Gynecol. 1990;33(4):817\u201325.","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"844_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/thy.2012.0361","volume":"23","author":"CP Camacho","year":"2013","unstructured":"Camacho CP, Lindsey SC, Melo MC, Yang JH, Germano-Neto F, FeO Valente, et al. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests. Thyroid. 2013;23(3):308\u201316. doi: 10.1089\/thy.2012.0361 .","journal-title":"Thyroid"},{"issue":"6","key":"844_CR20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3892\/mmr.2014.2656","volume":"10","author":"A Liu","year":"2014","unstructured":"Liu A, Huang W, Zeng G, Ma X, Zhou X, Wang Y, et al. Expression of the Annexin A1 gene is associated with suppression of growth, invasion and metastasis of nasopharyngeal carcinoma. Mol Med Rep. 2014;10(6):3059\u201367. doi: 10.3892\/mmr.2014.2656 .","journal-title":"Mol Med Rep"},{"key":"844_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju249","author":"GE Konecny","year":"2014","unstructured":"Konecny GE, Wang C, Winterhoff B, Kalli KR, Dering J, et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J Natl Cancer Inst. 2014. doi: 10.1093\/jnci\/dju249 .","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"844_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1089\/thy.2012.0180","volume":"22","author":"DS Duick","year":"2012","unstructured":"Duick DS, Klopper JP, Diggans JC, Friedman L, Kennedy GC, Lanman RB, et al. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology. Thyroid. 2012;22(10):996\u20131001. doi: 10.1089\/thy.2012.0180 .","journal-title":"Thyroid"},{"key":"844_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.106","author":"M Pino Del","year":"2014","unstructured":"Del Pino M, Svanholm-Barrie C, Torn\u00e9 A, Marimon L, Gaber J, Sagasta A, et al. mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer. Mod Pathol. 2014. doi: 10.1038\/modpathol.2014.106 .","journal-title":"Mod Pathol"},{"issue":"1","key":"844_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13000-014-0202-z","volume":"9","author":"P Krishnappa","year":"2014","unstructured":"Krishnappa P, Mohamad I, Lin Y, Barua A. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia. Diagn Pathol. 2014;9(1):202. doi: 10.1186\/s13000-014-0202-z .","journal-title":"Diagn Pathol"},{"issue":"20","key":"844_CR25","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/jnci\/djt235","volume":"105","author":"H Ikenberg","year":"2013","unstructured":"Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, et al. Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013;105(20):1550\u20137. doi: 10.1093\/jnci\/djt235 .","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"844_CR26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cncy.21366","volume":"122","author":"J Ordi","year":"2014","unstructured":"Ordi J, Sagasta A, Munmany M, Rodr\u00edguez-Carunchio L, Torn\u00e9 A, del Pino M. Usefulness of p16\/Ki67 immunostaining in the triage of women referred to colposcopy. Cancer Cytopathol. 2014;122(3):227\u201335.","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"844_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2249.2011.04504.x","volume":"167","author":"J Furuzawa-Carballeda","year":"2012","unstructured":"Furuzawa-Carballeda J, Lima G, Alber\u00fa J, Palafox D, Uribe-Uribe N, Morales-Buenrostro LE, et al. Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4\u03b1 senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A. Clin Exp Immunol. 2012;167(2):330\u20137. doi: 10.1111\/j.1365-2249.2011.04504.x .","journal-title":"Clin Exp Immunol"},{"key":"844_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2016.04.008","author":"J Hascitha","year":"2016","unstructured":"Hascitha J, Priya R, Jayavelu S, Dhandapani H, Selvaluxmy G, Sunder Singh S, et al. Analysis of kynurenine\/tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients. Clin Biochem. 2016. doi: 10.1016\/j.clinbiochem.2016.04.008 .","journal-title":"Clin Biochem"},{"issue":"2","key":"844_CR29","doi-asserted-by":"publisher","first-page":"e981457","DOI":"10.4161\/2162402X.2014.981457","volume":"4","author":"DM Ferns","year":"2015","unstructured":"Ferns DM, Kema IP, Buist MR, Nijman HW, Kenter GG, Jordanova ES. Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival. Oncoimmunology. 2015;4(2):e981457. doi: 10.4161\/2162402X.2014.981457 .","journal-title":"Oncoimmunology"},{"issue":"1","key":"844_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3835(92)90283-2","volume":"66","author":"BS Leung","year":"1992","unstructured":"Leung BS, Stout LE, Shaskan EG, Thompson RM. Differential induction of indoleamine-2,3-dioxygenase (IDO) by interferon-gamma in human gynecologic cancer cells. Cancer Lett. 1992;66(1):77\u201381.","journal-title":"Cancer Lett"},{"issue":"8","key":"844_CR31","first-page":"2629","volume":"31","author":"C Fotopoulou","year":"2011","unstructured":"Fotopoulou C, Sehouli J, Pschowski R, Von Haehling S, Domanska G, Braicu EI, et al. Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer. Anticancer Res. 2011;31(8):2629\u201335.","journal-title":"Anticancer Res"},{"key":"844_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4137\/IJTR.S4157","volume":"3","author":"R Sucher","year":"2010","unstructured":"Sucher R, Kurz K, Weiss G, Margreiter R, Fuchs D, Brandacher G. IDO-mediated tryptophan degradation in the pathogenesis of malignant tumor disease. Int J Tryptophan Res. 2010;3:113\u201320.","journal-title":"Int J Tryptophan Res"},{"issue":"3","key":"844_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2010.02.028","volume":"117","author":"T Inaba","year":"2010","unstructured":"Inaba T, Ino K, Kajiyama H, Shibata K, Yamamoto E, Kondo S, et al. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy. Gynecol Oncol. 2010;117(3):423\u20138. doi: 10.1016\/j.ygyno.2010.02.028 .","journal-title":"Gynecol Oncol"},{"issue":"2","key":"844_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ygyno.2012.07.098","volume":"127","author":"Q Feng","year":"2012","unstructured":"Feng Q, Wei H, Morihara J, Stern J, Yu M, Kiviat N, et al. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol. 2012;127(2):412\u20139. doi: 10.1016\/j.ygyno.2012.07.098 .","journal-title":"Gynecol Oncol"},{"issue":"12","key":"844_CR35","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1038\/jid.2013.222","volume":"133","author":"D Mittal","year":"2013","unstructured":"Mittal D, Kassianos AJ, Tran LS, Bergot AS, Gosmann C, Hofmann J, et al. Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7. J Invest Dermatol. 2013;133(12):2686\u201394. doi: 10.1038\/jid.2013.222 .","journal-title":"J Invest Dermatol"},{"issue":"3","key":"844_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/LGT.0b013e31802efb9e","volume":"11","author":"A Longatto-Filho","year":"2007","unstructured":"Longatto-Filho A, Etlinger D, Pereira SM, Kanamura CT, di Loreto C, GaC Santos, et al. The association of p16(INK4A) and fragile histidine triad gene expression and cervical lesions. J Low Genit Tract Dis. 2007;11(3):151\u20137. doi: 10.1097\/LGT.0b013e31802efb9e .","journal-title":"J Low Genit Tract Dis"},{"issue":"8","key":"844_CR37","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1055-9965.1355.13.8","volume":"13","author":"SS Wang","year":"2004","unstructured":"Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, Burk RD, et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomark Prev. 2004;13(8):1355\u201360.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"844_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","volume":"35","author":"I Tsoumpou","year":"2009","unstructured":"Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009;35(3):210\u201320. doi: 10.1016\/j.ctrv.2008.10.005 .","journal-title":"Cancer Treat Rev"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0844-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-016-0844-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0844-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T18:33:15Z","timestamp":1657477995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-016-0844-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1007\/s12032-016-0844-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]},"article-number":"132"}}